FDA-cleared cardiac scale and connected care platform for remote fluid management and heart failure monitoring.
Bodyport offers the FDA-cleared Bodyport Cardiac Scale, which noninvasively measures weight, peripheral impedance, pulse rate, and balance through the feet in under 30 seconds, transmitting data over cellular to care teams within minutes. A companion Congestion Index metric combines multiple parameters into a composite signal for detecting longitudinal changes in congestion; in the SCALE-HF 1 study, elevated Congestion Index preceded 70% of adjudicated worsening heart failure events. The platform includes a clinical portal with customizable monitoring rules, patient prioritization, API and EHR integrations, and SOC 2 Type 2 assessment. Bodyport is a product of Bodyport.